 |
Online Guide to EBM:
Solving a clinical problem using a Clinical Prediction
"rule"
Notes on using
the lecture
|
|
1) What is a clinical
prediction "rule"?
2) Why should I use one?
3) Ask The Question
4) Finding the
Evidence: choosing a source
5) Finding the Evidence:
constructing a search strategy (OVID)
6) Reading the Study:
Is it Valid?
7) What are the Results?
8) Will the results
help me care for my patient?
9) Will the results
change my management? |
|
| 1)What is a Clinical Prediction
Tool (CPT)? |
A clinical prediction tool has been defined as 3 or more variables
from the history, physical examination or simple ancillary tests1.
When input into a prediction model, these variables yield an estimate of
the probability of disease presence, or of a specific event occurring.
Clinical Prediction models take several
forms.
|
| 2) Why use a clinical prediction
tool? |
Many of the clinical decisions we make are based upon dogma passed
down through generations of house officers. Few are based on validated
evidence. This does not imply that most decisions are wrong.
However, utilizing medical dogma (all patients with new onset CHF must
be admitted), gestalt, and personal observation is sub-optimal. Clinical
prediction tools allow clinicians to make more precise estimates of the
probability of disease presence, absence, or of a specific event occurring.
|
| 3) Ask the Question |
|
|
This is similar to posing a question for a diagnostic test search,
except the test we are evaluating is a clinical prediction tool.
The question has 4 parts:
What is the disease or condition of interest
What is the test of interest?: a clinical prediction rule
What is the comparison test (gold standard comparison), if any
What do we want to know about the test, e.g. what is the "test"
related outcome of interest?: how
we want to measure the value of the CPT
|
| 4) Finding the
Evidence: Choosing a source. |
|
|
As usual, the best yield is through one of the NLM databases.
Again, the TRIP
database is a good place to start if you are short on time. Several
sites provide online, interactive, clinical prediction tools.
However, to critically evaluate these tools you must review the original
report on the tool.
|
| 5) Finding the evidence: Constructing a
strategy (OVID) |
|
|
If you have not already done so, this is a good point to stop
and read more about literature searching.
Try the following:
-
Search for the test (search filter for CPT's).
There is no MeSH heading "clinical prediction" Enter the following
in the OVID search box:
exp logistic models/ or exp models, theoretical/ or exp probability/
or exp multivariate analysis or *decision support techniques
-
Search the disease of interest
-
Combine 1 AND 2
-
If you came up with too many citations go on and Search the outcome:
Enter
exp "sensitivity and specificity"/
-
Combine 3 (product of 1 AND 2) and 4 (the outcome search)
-
See an example of this strategy

If you don't find what you want here are some additional search tips:
|
| 6) Reading the study: is it valid
(based
on standards of Laupacis et al1) |
|
|
The question of validity can be divided into 5 separate questions
-
Are the predictors valid? potential
predictor variables should be prospectively defined, clearly
defined, and should be reliable. During model development or validation,
the presence or absence (or value of) the predictors under investigation
should be prospectively recorded by individuals blinded to outcome data.
-
Is the decision tool outcome valid? The outcome which the decision
model predicts should be clinically relevant, and be clearly defined.
Persons determining the outcome should be blinded to other clinical information
and predictor values.
-
Methods and reporting. The mathematical
techniques used to derive the rule should be reported.
The demographic characteristics of the population should be clearly reported.
Without this information readers cannot assess the applicability of results
to other populations (issues of spectrum bias).
-
Have the results been validated? Many apparently well designed
studies do not perform well in validation studies. Prior to widespread
implantation of a clinical prediction model, it is important to establish
the models "transportability" to other settings. Several methods are used
for validation, but a prospective validation in a different setting is
most important.

-
Did they include too many predictor variables in the final rule? The
number of outcome events (fractures, MI's) in the derivation population
should be at least 10 times the number of predictor variables included.

|
| 7) What were the result
(how does the model perform) ? |
|
|
This can be divided into 4 separate issues
-
Categorization: How does the model categorize patients? For
the model to be of value it must divide patients into meaningful groups.
-
Discrimination: How accurately does the tool categorize patients? This
is often expressed as sensitivity, specificity, predictive values, likelihood
ratios, and by ROC analysis. If these values are not reported, try
to calculate them.
-
Calibration: How well does the model fit the data? Look for tabular
or graphic data showing predicted vs actual results for the patient population
under investigation. This is particularly important when the a tool uses
continuos or multiple risk stratification's.

-
Precision: Are confidence intervals on the results reported? If
not, try to Calculate
these.
|
| 8) Will the results help me care
for my patient? |
|
|
-
Is the tool easily usable? Some models, particularly those using
regression equations in the final model, require complex calculations or
a computer. Most models employing regression equations in the final form
require a computer.
-
Do the results apply to my patient? Derivation and/or validation
populations should be similar to yours. Ask the question: would my
patient have been eligible for entry into the study?
-
Are the results meaningful? If the decision support tool doesn't
categorize patients into meaningful groups, or doesn't does this with adequate
accuracy, then the model will not be of help.
|
| 9) Will the results change my
management? |
|
|
-
Has the model been shown to improve outcome or decrease costs? Few
models survive to outcome level investigations
-
Does the model perform better than the alternatives: Although valid
and accurate, if a model doesn't perform better than alternative tests,
or physician judgment , it may be of little value for the experienced clinician.
-
Based on the above considerations, weigh the risks and benefits of using
the rule. This requires consideration of your own, and you patients,
values.
Back to the top |